News

Published on 3 May 2024 on Insider Monkey via Yahoo Finance

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript


Article preview image

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024

NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day and thank you for standing by. Welcome to the NovoCure Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Ingrid Goldberg.

NASDAQ.NVCR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

The life science industry recently gave folks diagnosed with pancreatic cancer the best news this...

Motley Fool · via Yahoo Finance 5 Dec 2024

How A $2.9 Billion Deal Sent This Biotech To The Stratosphere

The deal centers on a drug called PTC518, which uses splicing technology to control how proteins ...

Investor's Business Daily 3 Dec 2024

NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer...

On Monday, NovoCure Ltd (NASDAQ:NVCR) and Zai Lab Limited (NASDAQ:ZLAB) revealed topline data fro...

Benzinga · via AOL 3 Dec 2024

NVCR Stock Up as TTFields Therapy Meets Pancreatic Cancer Study Goals

Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic...

Zacks · via Yahoo Finance 3 Dec 2024

XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday - Akso...

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday. Shares o...

Benzinga 2 Dec 2024

Novocure's Stock Skyrockets Over 32% Amid Groundbreaking Pancreatic Cancer...

Add to that a 22% jump in third-quarter revenues and FDA approvals for cutting-edge products like...

GuruFocus.com · via Yahoo Finance 2 Dec 2024

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025

If you’re wondering what stocks to buy this month, look no further. Every investor wants their st...

InvestorPlace via Yahoo Finance 15 May 2024

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beat...

Insider Monkey via Yahoo Finance 3 May 2024

Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

Organon & Co. OGN is scheduled to release first-quarter 2024 results on May 2, before the opening...

Zacks via Yahoo Finance 1 May 2024

Aggressive Stock Portfolio: 13 Stocks Picked by Analysts

In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts....

Insider Monkey via Yahoo Finance 5 Apr 2024